[at noodls] – ST. PAUL, MN — (Marketwired) — 04/22/13 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 03/12/13 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 02/27/13 — EnteroMedics Inc., (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 02/20/13 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 02/13/13 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboardSee who EnteroMedics is hiring next, click here to view […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 11/19/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 11/15/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 11/07/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – ST. PAUL, MN — (Marketwire) — 11/06/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – Company to Host Conference Call Today, October 24, 2012, at 11:00 AM ET ST. PAUL, MN — (Marketwire) — 10/24/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking … moreView todays social media effects on ETRMView the latest stocks trending across Twitter. Click to view dashboard […]
